Compare CLDT & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDT | THW |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | 16 | N/A |
| Industry | Real Estate Investment Trusts | Finance Companies |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.5M | 516.7M |
| IPO Year | N/A | 2015 |
| Metric | CLDT | THW |
|---|---|---|
| Price | $13.36 | $13.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 389.3K | 160.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.13% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.94 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $610.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.08 | $10.17 |
| 52 Week High | $13.64 | $13.79 |
| Indicator | CLDT | THW |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 54.73 |
| Support Level | $6.26 | $12.33 |
| Resistance Level | $13.64 | $13.79 |
| Average True Range (ATR) | 0.34 | 0.23 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 78.33 | 34.19 |
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.